Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Slovakia Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20051
20062
20072
20082
20094
20102
20113
20124
20143
20161
20191
20214
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Active, not recruiting11
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Hoffmann-La Roche7
Novartis Pharmaceuticals5
AstraZeneca4
Eli Lilly and Company3
Sanofi3
Central European Cooperative Oncology Group2
GlaxoSmithKline2
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms42
Recurrence4
Neoplasm Metastasis3
Neoplasms3
Breast Diseases2
Neoplasms by Site2
Neutropenia2
Unilateral Breast Neoplasms2
Blast Crisis1
Burkitt Lymphoma1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.